MedPath

Clinolipid

These highlights do not include all the information needed to use CLINOLIPID safely and effectively. See full prescribing information for CLINOLIPID. CLINOLIPID (lipid injectable emulsion), for intravenous useInitial U.S. Approval: 1975

Approved
Approval ID

ae98eb03-c0e7-49d1-b024-77968e3d9d6e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 17, 2023

Manufacturers
FDA

Baxter Healthcare Corporation

DUNS: 005083209

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Olive Oil and Soybean Oil

PRODUCT DETAILS

NDC Product Code0338-9540
Application NumberNDA204508
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateJuly 20, 2016
Generic NameOlive Oil and Soybean Oil

INGREDIENTS (5)

OLIVE OILActive
Quantity: 16 g in 100 mL
Code: 6UYK2W1W1E
Classification: ACTIB
GLYCERINInactive
Quantity: 2.25 g in 100 mL
Code: PDC6A3C0OX
Classification: IACT
SODIUM OLEATEInactive
Quantity: 0.03 g in 100 mL
Code: 399SL044HN
Classification: IACT
SOYBEAN OILActive
Quantity: 4 g in 100 mL
Code: 241ATL177A
Classification: ACTIB
EGG PHOSPHOLIPIDSInactive
Quantity: 1.20 g in 100 mL
Code: 1Z74184RGV
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Clinolipid - FDA Drug Approval Details